“Treatment outcome with a second generation combination chemotherapeutic regimen m-BACOD and with a standard regimen chop for advance diffuse non-Hodgkin’s lymphoma in elderly patients”, J. Armed Forces Med. Coll., vol. 4, no. 2, pp. 27–32, Jan. 2009, doi: 10.3329/jafmc.v4i2.1842.